Open AccessFrequency and prognostic role of mucosal healing in patients with Crohn’s disease and ulcerative colitis after one-year of biological therapy
Author(s) -
Klaudia Farkas,
Péter L. Lakatos,
Mónika Szűcs,
É. Pallagi-Kunstár,
Anita Bálint,
Ferenc Nagy,
Zoltán Szepes,
Noémi Vass,
László Kiss,
Tibor Wittmann,
Tamás Molnár
Publication year - 2014
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v20.i11.2995
Subject(s) - medicine , ulcerative colitis , infliximab , gastroenterology , adalimumab , crohn's disease , disease , colitis , endoscopy , intestinal mucosa , surgery
To assess the endoscopic activity before and after a one-year period of biological therapy and to evaluate the frequency of relapses and need for retreatment after stopping the biologicals in patients with Crohn's disease (CD) and ulcerative colitis (UC).